These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17099949)

  • 1. A new approach to drug development.
    Mayer D
    N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17099949
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of neurologists in the pharmaceutical industry.
    Peroutka SJ
    West J Med; 1994 Sep; 161(3):328-30. PubMed ID: 7975576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to drug development.
    Frangioni JV
    N Engl J Med; 2006 Nov; 355(19):2046; author reply 2046. PubMed ID: 17099947
    [No Abstract]   [Full Text] [Related]  

  • 4. Litigation plays protective role--and is part of the problem.
    Kennett JD
    Mo Med; 2007; 104(1):12-3. PubMed ID: 17410818
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence of comparative efficacy should have a formal role in European drug approvals.
    Sorenson C; Naci H; Cylus J; Mossialos E
    BMJ; 2011 Sep; 343():d4849. PubMed ID: 21896610
    [No Abstract]   [Full Text] [Related]  

  • 6. A new approach to drug development.
    Brown S
    N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17099948
    [No Abstract]   [Full Text] [Related]  

  • 7. Former pharma pitchman: beware of new drugs. An industry insider advises considering the older options if you need a prescription. Interview by Sarah Baldauf.
    Nesi T
    US News World Rep; 2008 Nov 3-10; 145(10):64. PubMed ID: 18998444
    [No Abstract]   [Full Text] [Related]  

  • 8. A new approach to drug development.
    Guda HE
    N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17093258
    [No Abstract]   [Full Text] [Related]  

  • 9. [False innovations in clinical research].
    Garattini S; Bertele' V
    Recenti Prog Med; 2006 Nov; 97(11):611-7. PubMed ID: 17252717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Academic drug detailing: an evidence-based alternative.
    Kondro W
    CMAJ; 2007 Feb; 176(4):429-31. PubMed ID: 17296946
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis.
    Garrison LP; Towse A; Bresnahan BW
    Health Aff (Millwood); 2007; 26(3):684-95. PubMed ID: 17485745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US drug industry bans expensive freebies for MDs, Canada raises fines.
    Sibbald B
    CMAJ; 2002 Sep; 167(5):522. PubMed ID: 12240824
    [No Abstract]   [Full Text] [Related]  

  • 13. Time to nip "seeding trials" in the bud.
    Katz KA
    Arch Dermatol; 2008 Mar; 144(3):403-4. PubMed ID: 18347299
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicines and people in the Third World--the role of the industry. The Association of the Danish Pharmaceutical Industry (MEFA).
    Dan Med Bull; 1984 Nov; 31 Suppl 1():6-8. PubMed ID: 6518831
    [No Abstract]   [Full Text] [Related]  

  • 15. The marketplace can't give us the drug safety data we need.
    Avorn J
    MedGenMed; 2007 Feb; 9(1):29. PubMed ID: 17435636
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
    Reeve LM
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):181-7. PubMed ID: 19589365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The function of the physician in the pharmaceutical industry].
    Vallvé C
    Med Clin (Barc); 1983 Nov; 81(16):717-9. PubMed ID: 6656427
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law.
    Dinh TQ
    Food Drug Law J; 2007; 62(1):77-137. PubMed ID: 17444027
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence-based medicine: our responsibility to our patients.
    Hartrick CT
    Pain Pract; 2007 Sep; 7(3):219-20. PubMed ID: 17714099
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.